Completed NA INTERVENTIONAL 2-arm NCT03083951

Complete Mesocolon Excision vs Locoregional Lymphadenectomy in Sigmoid Colon Cancer (CMELL) (CMELL)

Sponsor: Pere Planellas Giné

Conditions Colorectal Cancer Sigmoid Cancer

Interventions Complete mesocolon excision Conventional locoregional lymphadenectomy

Updated 8 times since 2017 Last updated: Sep 28, 2023 Started: Sep 1, 2017 Primary completion: Jun 1, 2019 Completion: Jan 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03083951, this NA trial focuses on Colorectal Cancer and Sigmoid Cancer and remains completed. Sponsored by Pere Planellas Giné, it has been updated 8 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Oct 2023 — Jul 2024 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Oct 2021 — Oct 2023 [monthly]

Active Not Recruiting NA
Jan 2021 — Oct 2021 [monthly]

Active Not Recruiting NA

▶ Show 3 earlier versions

Oct 2019 — Jan 2021 [monthly]

Active Not Recruiting NA

Status: Not Yet Recruiting → Active Not Recruiting · Phase: PHASE4 → NA
Jun 2018 — Oct 2019 [monthly]

Not Yet Recruiting PHASE4
May 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pere Planellas Giné

Data source: Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Girona, Spain